Literature DB >> 842561

Acute myelofibrosis and malignant hypercalcemia.

J A Libnoch, K Ajlouni, W L Millman, A R Guansing, G B Theil.   

Abstract

A 33 year old man presented with symptoms of one week's duration; he had a serum calcium of 22.5 mg/dl and a markedly hypercellular bone marrow. Despite therapy with saline diuresis, furosemide mithramycin, total parathyroidectomy and corticosteroids, symptomatic hypercalcemia was poorly controlled. Inappropriate serum parathyroid hormone (PTH) levels were found before and after parathyroidectomy whereas assays of the peripheral blood for osteoclast-activating factor and prostaglandin E (PGE2) were negative. An elevated leukocyte alkaline phosphate level, the inability to aspirate marrow, the marked generalized hyperplasia of all hematopoietic marrow elements, the focal accumulations of blastic cells and increasing reticulin fiber formation led to the diagnosis of acute myelofibrosis. A single course of cytosine arabinoside and thioguanine therapy was followed by profound hyperphosphatemia, hypocalcemia and death. The rarity of hypercalcemia with myeloproliferative disorders is documented by a review of the world literature, and the possible mechanism for hypercalcemia in this patient is discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 842561     DOI: 10.1016/0002-9343(77)90843-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  4 in total

Review 1.  The pathophysiology and clinical aspects of hypercalcemic disorders.

Authors:  D B Lee; E T Zawada; C R Kleeman
Journal:  West J Med       Date:  1978-10

2.  Thorotrast administration followed by myelofibrosis.

Authors:  A G Arnold; M H Oelbaum
Journal:  Postgrad Med J       Date:  1980-02       Impact factor: 2.401

3.  Artefactual serum hyperkalaemia and hypercalcaemia in essential thrombocythaemia.

Authors:  M R Howard; S Ashwell; L R Bond; I Holbrook
Journal:  J Clin Pathol       Date:  2000-02       Impact factor: 3.411

4.  Hypercalcemia and diffuse osteolytic lesions in a 45-year-old patient with myeloid sarcoma with megakaryocytic differentiation.

Authors:  Aditya Goud; Abdelhai Abdelqader; Chanukya Dahagam; Ramez Jabaji; Pallavi Kumar; Albert Aboulafia; Stephen Selinger
Journal:  J Community Hosp Intern Med Perspect       Date:  2016-04-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.